ADVERTISEMENT

Buy Vertex Pharma. Its cystic fibrosis drug combination was recommended for approval on Tuesday.

njfan47

Well-Known Member
Jan 8, 2009
3,337
41
48
The stock could gain $20 or more in the next month and the company could be a takeover candidate. One caveat is that the market for this particular drug is small, in the range of 8,000 to 28,000, depending on the source.

Jeff Masters, a cystic fibrosis patient from Michigan, told the FDA advisory committee that the drug has changed his life. A high school soccer and lacrosse player from Maine told the committee that the drug has had a profound impact on her life.

The amount of patients might be able to be increased over time as the drug is modified, although that is not certain at this point. This is a story of good news all around. The athlete from Maine said she was humbled by the medical technology that allowed her to speak to the advisory committee.
 
ADVERTISEMENT
ADVERTISEMENT